Abstract
The fruit of Schisandra chinensis (Chinese magnolia vine) is one of the many raw materials derived from traditional Chinese medicine that is appreciated in modern phytotherapy, as well as in the cosmetics and food industries. Apart from this raw material, the lesser-known fruit of S. sphenanthera is also highly valued in Far Eastern medicine. This species is often confused with S. chinensis. In this chapter, comparative characteristics of both species are presented. Particular attention is paid to the differences in their occurrence, chemical compositions and possible applications. A broad review of the scientific literature has been made, and the most important information on the biological activity, industrial use and the progress in biotechnology research on the two species has been collected.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akula R, Ravishankar GA (2011) Influence of abiotic stress signals on secondary metabolites in plants. Plant Signal Behav 6:1720–1731. https://doi.org/10.4161/psb.6.11.17613
Alexander J, Wang Y (2012) Therapeutic potential of Schisandra chinensis extracts for treatment of hypertension. Hypertens Res 35:892–893. https://doi.org/10.1038/hr.2012.101
Bensky D, Gamble A (1993) Chinese herbal medicine materia. Medica. https://doi.org/10.4236/eng.2013.510B001
Bi H, Li F, Krausz KW, et al (2013) Targeted metabolomics of serum acylcarnitines evaluates hepatoprotective effect of Wuzhi tablet (Schisandra sphenanthera extract) against acute acetaminophen toxicity. Evid Based Complement Altern Med 2013: ID 985257. https://doi.org/10.1155/2013/985257
Březinová L, Vlašínová H, Havel L et al (2010) Validated method for bioactive lignans in Schisandra chinensis in vitro cultures using a solid phase extraction and a monolithic column application. Biomed Chromatogr 24:954–960. https://doi.org/10.1002/bmc.1391
Casarin E, Dall’Acqua S, Smejkal K, Al E (2014) Molecular mechanisms of antiproliferative effects induced by Schisandra-derived dibenzocyclooctadiene lignanas (+)-deoxyschisandrin and (−)-gomisin N in human tumour cell lines. Fitoterapia 98:241–247.https://doi.org/10.1016/j.fitote.2014.08.001
Central Pharmaceutical Affairs Council of Korea (2002) Korean Pharmacopoeia. Seoul
Chen AH, Yang JL, Da NY et al (2010) High-frequency somatic embryogenesis from germinated zygotic embryos of Schisandra chinensis and evaluation of the effects of medium strength, sucrose, GA3, and BA on somatic embryo development. Plant Cell Tissue Organ Cult 102:357–364. https://doi.org/10.1007/s11240-010-9740-6
Chen X, Zhang Y, Zu Y, Al E (2011) Composition and biological activites of the essential oil from Schisandra chinensis obtained by solvent-free microwave extraction. LWT Food Sci Technol 44:2047–2052. https://doi.org/10.1016/j.lwt.2011.05.013
Chen Y, Tang J, Wang X, et al (2012) An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill. Int J Biol Macromol 50:844–848. https://doi.org/10.1016/j.ijbiomac.2011.11.015
Chen YC, Liaw CC, Bin CY et al (2013) Anti-liver fibrotic lignans from the fruits of Schisandra arisanensis and Schisandra sphenanthera. Bioorg Med Chem Lett 23:880–885. https://doi.org/10.1016/j.bmcl.2012.11.040
Cheng N, Ren N, Gao H et al (2013) Antioxidant and hepatoprotective effects of Schisandra chinensis pollen extract on CCl4-induced acute liver damage in mice. Food Chem Toxicol 55:234–240. https://doi.org/10.1016/j.fct.2012.11.022
Chen X, Tang R, Liu T et al (2019) Physicochemical properties, antioxidant activity and immunological effects in vitro of polysaccharides from Schisandra sphenanthera and Schisandra chinensis. Int J Biol Macromol 131:744–751. https://doi.org/10.1016/j.ijbiomac.2019.03.129
Chinese Pharmacopoeia Commission (2005) Pharmacopoeia of the People’s Republic of China. China Chemical Industry Press, Bei**g
Chiu P, Lam P, Yan C, Ko K (2011) Schisandrin B protects against solar irradation-induced oxidative injury in BJ human fibroblasts. Fitoterapia 82:682–691. https://doi.org/10.1016/j.fitote.2010.11.018
Choi DY, Lee YJ, Hong JT, Lee HJ (2012) Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer’s disease. Brain Res Bull 87:144–153. https://doi.org/10.1016/j.brainresbull.2011.11.014
Chu IYE, Kurtz SL (1990) Commercialization of plant micropropagation. Handbook of plant cell culture, vol 5. Ornamental species. McGraw-Hill Inc., New York, pp 126–164
Chun J, Cho M, So I, Al E (2014) The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms. Fitoterapia 97:224–233. https://doi.org/10.1016/j.fitote.2014.06.014
Committee of the Japanese Pharmacopoeia Evaluation and Licensing Division Pharmaceuticals and Food Safety (2006) Japanese Pharmacopoeia. Bureau Ministry of Health, Labour and Welfare, Tokyo
Cunningham A, Brinckmann J (2010) “Cinderella” Schisandra: a project linking conservation and local livelihoods in the upper yangtze ecoregion of China. J Am Bot Counc 28–39. https://doi.org/10.1016/j.jep.2018.05.042
Dias MI, Sousa MJ, Alves RC, Ferreira ICFR (2016) Exploring plant tissue culture to improve the production of phenolic compounds: a review. Ind Crops Prod 82(9), 22. https://doi.org/10.1016/j.indcrop.2015.12.016
Du W, **ao-Fan W (2012) Intercarpellary growth of pollen tubes in the extragynoecial compitum and its contribution to fruit set in an apocarpous species, Schisandra sphenanthera (Schisandraceae). Am J Bot 99:961–966. https://doi.org/10.3732/ajb.1100165
European Commission Cosing (2020) CosIng—cosmetic Database
European Directorate for the Quality of Medicine (2010) European pharmacopoeia 10.0. Strasbourg
European Food Safety Authority Botanical Summary Report|European Food Safety Authority
Fan X, Jiang Y, WAng Y, Al E (2014) Wuzhi tablet (Schisandra sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p35/p21 pathways. Drug Metab Dispos 42:1982–1990. https://doi.org/10.1016/j.apsb.2017.04.002
Garnier S, Msika P (2013) Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical composition comprising, United States Patent, US 8,586,107 B2
Garnier S, Naaimi D, Baudouin C (2012) Cosmetic composition for the treatment of acne comprising a peptide extracts of Schizandra, France, FR2948565B1
Gopaul R, Kern D, Knaggs H, Lephart J (2012) Narcissus tazetta and Schizandra chinensis to regulate ‘Youth Gene Clusters’—an in vitro analysis. Cosmet Toiletries 446–448
Guo Y, Wei H, Lu C, et al (2016) Predictions of potential geographical distribution and quality of Schisandra sphenanthera under climate change. PeerJ 1–21.https://doi.org/10.7717/peerj.2554
Hancke JL, Burgos RA, Ahumada F (1999) Schisandra chinensis (Turcz.) Baill. Fitoterapia 70:451–471. https://doi.org/10.1016/S0367-326X(99)00102-1
Havel L, Vlašínová H, Bohatcová I et al (2008) Dibenzocyclooctadiene lignan production in Schisandra chinensis embryogenic culture. J Biotechnol 136:S437. https://doi.org/10.1016/j.jbiotec.2008.07.1012
Hill RA, Connolly JD (2013) Triterpenoids. Nat Prod Rep 30:1028–1065.https://doi.org/10.1039/c3np70032a. http://www.theplantlist.org/
Hu D, Yang Z, Yao X et al (2014) Dibenzocyclooctadiene lignans from Schisandra chinensis and their inhibitory activity on NO production in lipopolysaccharide-activated microglia cells. Phytochemistry 104:72–78. https://doi.org/10.1016/j.phytochem.2014.04.014
Huang S, Yang J, Huang H, Al. E (2007) Structural characterization of schintrilactone, a new class of nortriterpenoids from Schisandra chinensis. Org Lett 9:4175–4178. https://doi.org/10.1021/ol701679n
Huang S, Han Q, Lei C, Al E (2008) Isolation and characterization of miscellaneous terpenoids of Schisandra chinensis. Tetrahedron 64:4260–4267. https://doi.org/10.1016/j.tet.2008.02.085
Huang HC, Lin YC, Fazary AE et al (2011) New and bioactive lignans from the fruits of Schisandra sphenanthera. Food Chem 128:348–357. https://doi.org/10.1016/j.foodchem.2011.03.030
Huyke C, Engel K, Simon-Haarhaus B et al (2007) Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis. Planta Med 73:1116–1126. https://doi.org/10.1055/s-2007-981559
Hwang H, Kim I, Kwon IC, Kim Y (2008) Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 128:23–31. https://doi.org/10.1016/j.jconrel.2008.02.003
Hwang D, Shin SY, Lee Y et al (2011) A compound isolated from Schisandra chinensis induces apoptosis. Bioorg Med Chem Lett 21:6054–6057. https://doi.org/10.1016/j.bmcl.2011.08.065
Ikeya Y, Taguchi H, Yosioka I, Kobayashi H (1979a) The constituents of Schizandra chinensis Baill. The cleavage of the methylenedioxy moiety with lead tetraacetate in benzene, and the structure of angeloylgomisin. Q Chem Pharm Bull 27:2536–2538
Ikeya Y, Taguchi H, Yosioka I, Kobayashi H (1979b) The constituents of Schizandra chinensis Baill. III. The structures of four new lignans, gomisin H and its derivative, angeloyl-, tigloyl- and benzoylgomisin H. Chem Pharm Bull 27:1576–1582
Ip SP, Che CT, Kong YC, Ko KM (2001) Effects of schisandrin B pretreatment on tumor necrosis factor-alpha induced apoptosis and Hsp70 expression in mouse liver. Cell Stress Chaperones 6:44–48
Jiang ZT, Li R, Yu JC (2006) Pungent components from thioglucosides in Armoracia rusticana grown in China, obtained by enzymatic hydrolysis. Food Technol Biotechnol 44:41–45
Jiang K, Song QY, Peng SJ, et al (2015a) New lignans from the roots of Schisandra sphenanthera. Fitoterapia 103:63–70.https://doi.org/10.1016/j.fitote.2015.03.015
Jiang Y, Fan X, Wang Y, et al (2015b) Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chem Biol Interact 231:83–89.https://doi.org/10.1016/j.cbi.2015.02.022
** J, Bi H, Hu J, Al E (2011) Effects of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of pacliaxtel in rats. Phytother Res 25:1250–1253. https://doi.org/10.1002/ptr.3407
Kam Ming K, Jun Y, Chuixin Q (2015) Schisandra Chinensis: an herb of North Eastern China origin. World Scientific Publishing, Singapore
Kang Y, Shin H (2012) Inhibitory effects of Schizandra chinensis extract on atopic dermatitis in NC/Nga mice. Immunopharmacol Immunotoxicol 34:292–298. https://doi.org/10.3109/08923973.2011.602689
Karuppusamy S (2007) A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures. J Med Plants Res 3:1222–1239. https://doi.org/10.5897/JMPR
Kim SR, Lee MK, Koo KA et al (2004) Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity. J Neurosci Res 76:397–405. https://doi.org/10.1002/jnr.20089
Kirakosyan A, Kaufman PB (2009) Recent advances in plant biotechnology, 1-409. https://doi.org/10.1007/978-1-4419-0194-1
Kochetkov N, Khorlin A, Chizhov O, Al E (1961) Schizandrin—lignan of unusual structure. Tetrahedron Lett 2:730–734. https://doi.org/10.1016/S0040-4039(01)91684-3
Kohda H, Ozaki M, Namera A (2012) Production of lignans in calluses of Schisandra chinensis. J Nat Med 66:373–376. https://doi.org/10.1007/s11418-011-0586-y
Kwan HY, Niu X, Dai W et al (2015) Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers. Sci Rep 5:1–14. https://doi.org/10.1038/srep09114
Lam P, Yan C, Chiu P et al (2011) Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue. Fitoterapia 82:393–400. https://doi.org/10.1016/j.fitote.2011.02.010
Lee HJ, Cho IH, Lee KE, Kim YS (2011) The compositions of volatiles and aroma-active compounds in dried omija fruits (Schisandra chinensis Baillon) according to the cultivation areas. J Agric Food Chem 59:8338–8346. https://doi.org/10.1021/jf200762h
Li L, Lu Q, Shen Y, Hu X (2006) Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem Pharmacol 71:584–595. https://doi.org/10.1016/j.bcp.2005.11.026
Li W, Yan C, Wu Y et al (2014) Osteoblasts proliferation and differentiation stimulating activities of the main components of Fructus Psoraleae corylifoliae. Phytomedicine 21:400–405. https://doi.org/10.1016/j.phymed.2013.09.015
Liang C, Hu J, Shi Y, Al E (2013) Schisphenlignans A-E: five new dibenzocyclooctadiene lignans from Schisandra sphenanthera. Chem Pharm Bull 61:96–100. https://doi.org/10.1248/cpb.c12-00700
Li Z, He X, Liu F et al (2018) A review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: Properties, functions and applications. Carbohyd Polym 184:178–190. https://doi.org/10.1016/j.carbpol.2017.12.058
Liang W, Deng B, **ao J, Wang S (2011) Effects of basic media and culture conditions on callus growth and polysaccharide content in Schisandra sphenanthera. J Central South Univ For Technol
Liu C, Fang S, Huang M, Al E (1978) Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds. Sci Sinica 21:483–502
Liu HW, Yu XZ, Padula D et al (2013) Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity. Eur J Med Chem 59:265–273. https://doi.org/10.1016/j.ejmech.2012.11.003
Lu H, Liu GT (1992) Anti-oxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae. Planta Med 58:311–313. https://doi.org/10.1055/s-2006-961473
Lu Y, Chen DF (2009) Analysis of Schisandra chinensis and Schisandra sphenanthera. J Chromatogr A 1216:1980–1990. https://doi.org/10.1016/j.chroma.2008.09.070
Paula MW (2012) The status of temporary immersion system (TIS) technology for plant micropropagation. Afr J Biotech 11:14025–14035.https://doi.org/10.5897/ajb12.1693
Matkowski A (2008) Plant in vitro culture for the production of antioxidants—a review. Biotechnol Adv 26:548–560. https://doi.org/10.1016/j.biotechadv.2008.07.001
Miao M, Gao J, Zhang G, et al (2009) Effect of Schisandra chinensis polysaccharide on intracerebral acetylcholinesterase and monoamine neurotransmitters in a D-galactose-induced aging brain mouse model. Neural Regeneration Res 4:687–693. https://doi.org/10.3969/j.issn.1673-5374.2009.09.009
Mocan A, Crişan G, Vlase L et al (2014) Comparative studies on polyphenolic composition, antioxidant and antimicrobial activities of schisandra chinensis leaves and fruits. Molecules 19:15162–15179. https://doi.org/10.3390/molecules190915162
Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tabacco tissue cultures. Physiol Plant 15:473–497. https://doi.org/10.1016/S0031-9422(01)00179-0
Opletal L, Sovova H, Bartlova M (2004) Dibenzo [a, c] cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. J Chromatogr B 812:357–371. https://doi.org/10.1016/j.jchromb.2004.07.040
Pan S-Y, Chen S-B, Dong H-G, et al (2011) New perspectives on chinense herbal medicine (zhong-yao) research and development. Evid Based Complement Altern Med 1–11.https://doi.org/10.1093/ecam/neq056
Panossian A, Wagner H (2005) Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res 19:819–838. https://doi.org/10.1002/ptr.1751
Panossian A, Wikman G (2008) Pharmocology of Schisandra chinensis Bail: an overview of Russian research and uses in medicine. J Ethnopharmacol 118:183–212
Park E, Chun J, Kim S, Al E (2012) Schisandrin B supresses TGF- β1 signaling by inhibiting Smad2/3 and MAPK pathways. Biochem Pharmacol 83:378–384. https://doi.org/10.1016/j.bcp.2011.11.002
Park S, Kim J, Jeong K et al (2013) Antioxidant activity and inhibition of MMP-1 expression of Schizandrae fructus (Schizandra chinensis) extract. Korean J Pharmacognosy 1:47–52
Pietrosiuk A, Furmanowa M (2006) Plant biotechnology in human healthcare. Biotechnologia 116–123
Qiangrong P, Wang T, Lu Q, Hu X (2005) Schisandrin B—a novel inhibitor of P-glycoprotein. Biochem Biophys Res Commun 335:406–411. https://doi.org/10.1016/j.bbrc.2005.07.097
Qin X, Bi H, Wang X, Al E (2010) Mechanistic understanding of the different effects of Wuzhi tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK 506). Int J Pharm 389:114–121. https://doi.org/10.1016/j.ijpharm.2010.01.025
Qin XL, Chen X, Wang Y et al (2014) In vivo to in vitro effects of six bioactive lignans of wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/pglycoprotein-mediated absorption and metabolism of tacrolimus. Drug Metab Dispos 42:193–199. https://doi.org/10.1124/dmd.113.053892
Ren R, Ci X, Lia H, Al E (2010) New dibenzocyclooctadiene lignans from Schisandra sphenanthera and thier proinflammatory cytokine inhibitory activites. Z Naturforsch 65:211–218. https://doi.org/10.1016/j.bmc.2004.12.020
Saunders RM (2000) Monograph of Schisandra (Schisandraceae ). Am Soc Plant Taxonomists 58:1–146
Shaitan I (2005) Кoлбacинa EИ: Aктиндия и лимoнник (Actinidia and Chinese Magnolia vine). In: Издaтeльcкий Дoм MCП. Moscow
Shi Y, Zhong W, Chen H, Al E (2014) New lignans form the leaves and stems of Schisandra chinensis an their anti-HIV activites. Chin J Chem 32:734–740. https://doi.org/10.1002/cjoc.201400001
Shuwei L, Haidong C (2000) On the indications of bifendate. Adverse Drug React J 2:225–228. https://doi.org/10.1016/s0140-6736(00)02219-4
Slanina J, Táborská E, Lojková L (1997) Lignans in the seeds and fruits of Schisandra chinensis cultured in Europe. Planta Med 63:277–280. https://doi.org/10.1055/s-2006-957676
So-Ra C, Chang-Su K, Jong-Yeob K et al (2011) Changes of antioxidant activity and lignan contents in Schisandra chinensis by harvesting times. Korean J Med Crop Sci 19:414–420
Song L, Ding JY, Tang C, Yin CH (2007) Compositions and biological activities of essential oils of Kadsura longepedunculata and Schisandra sphenanthera. Am J Chin Med 35:353–364. https://doi.org/10.1142/S0192415X07004874
Song QY, Zhang CJ, Li Y et al (2013) Lignans from the fruit of Schisandra sphenanthera, and their inhibition of HSV-2 and adenovirus. Phytochem Lett 6:174–178. https://doi.org/10.1016/j.phytol.2012.12.008
Sovová H, Opletal L, Bártlová M et al (2007) Supercritical fluid extraction of lignans and cinnamic acid from Schisandra chinensis. J Supercrit Fluids 42:88–95. https://doi.org/10.1016/j.supflu.2007.01.008
Sun Y, Wen X, Huang H (2010) Population genetic differentiation of Schisandra chinensis and Schisandra sphenanthera as revealed by ISSR analysis. Biochem Syst Ecol 38:257–263. https://doi.org/10.1016/j.bse.2010.01.005
Szopa A, Ekiert H (2011) Lignans in Schisandra chinensis in vitro cultures. Pharmazie 66:633–634
Szopa A, Ekiert H (2012) In vitro cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine)—a potential biotechnological rich source of therapeutically important phenolic acids. Appl Biochem Biotechnol 166:1941–1948. https://doi.org/10.1007/s12010-012-9622-y
Szopa A, Ekiert H (2013) Production of deoxyschizandrin and γ-schizandrin in shoot-differentiating and undifferentiating callus cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine). J Biotechnol 165:209–213. https://doi.org/10.1016/j.jbiotec.2013.03.010
Szopa A, Ekiert H (2014) Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) in vitro cultures. In: Govil JN (ed) Recent progress in medicinal plants. Biotechnology and genetic engineering II, 39th edn. Studium Press LLC, USA, pp 405–434
Szopa A, Ekiert H (2015) Production of schisantherin A and gomisin G in in vitro cultures of Schisandra chinensis. Phytochem Lett 11:440–444. https://doi.org/10.1016/j.phytol.2014.12.022
Szopa A, Ekiert H (2016) The importance of applied light quality on the production of lignans and phenolic acids in Schisandra chinensis (Turcz.) Baill. cultures in vitro. Plant Cell, Tissue Organ Cult 127:115–121. https://doi.org/10.1007/s11240-016-1034-1
Szopa A, Kisiel W, Ekiert H, Szewczyk A (2015) Isolation of three dibenzocyclooctadiene lignans from in vitro cultures of Schisandra chinensis (Turcz.) Baill.—the first report. Pharmazie 70:337–339. https://doi.org/10.1691/ph.2015.4779
Szopa A, Kokotkiewicz A, Marzec-Wróblewska U et al (2016) Accumulation of dibenzocyclooctadiene lignans in agar cultures and in stationary and agitated liquid cultures of Schisandra chinensis (Turcz.) Baill. Appl Microbiol Biotechnol 100:3965–3977. https://doi.org/10.1007/s00253-015-7230-9
Szopa A, Ekiert R, Ekiert H (2017) Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem Rev 16:195–218. https://doi.org/10.1007/s11101-016-9470-4
Szopa A, Dziurka M, Warzecha A, Kubica P, Klimek-Szczykutowicz M, Ekiert H (2018a) Targeted lignan profiling and anti-inflammatory properties of Schisandra rubriflora and Schisandra chinensis extracts. Molecules 23:3103.https://doi.org/10.3390/molecules23123103
Szopa A, Klimek-Szczykutowicz M, Kokotkiewicz A, et al (2018b) Phytochemical and biotechnological studies on Schisandra chinensis cultivar Sadova No. 1—a high utility medicinal plant. Appl Microbiol Biotechnol 102:5105–5120.https://doi.org/10.1007/s00253-018-8981-x
Szopa A, Kokotkiewicz A, Król A, et al (2018c) Improved production of dibenzocyclooctadiene lignans in the elicited microshoot cultures of Schisandra chinensis (Chinese magnolia vine). Appl Microbiol Biotechnol 102:945–959.https://doi.org/10.1007/s00253-017-8640-7
Szopa A, Warzecha A, Klimek-Szczykutowicz M, Stańczyk K (2018d) Cytryniec chiński (Schisandra chinensis (Turcz.) Baill.)—z tradycyjnej medycyny chińskiej do współczesnej fitoterapii. Herbalism 1:101–119
Szopa A, Klimek-Szczykutowicz M, Kokotkiewicz A, et al (2019a) Phenolic acid and flavonoid production in agar, agitated and bioreactor-grown microshoot cultures of Schisandra chinensis cv. Sadova No. 1—a valuable medicinal plant. J Biotechnol 305:61–70.https://doi.org/10.1016/j.jbiotec.2019.08.021
Szopa A, Kokotkiewicz A, Bednarz M, et al (2019b) Bioreactor type affects the accumulation of phenolic acids and flavonoids in microshoot cultures of Schisandra chinensis (Turcz.) Baill. Plant Cell, Tissue Organ Cult 139:199–206.https://doi.org/10.1007/s11240-019-01676-6
Szopa A, Kokotkiewicz A, Klimek-Szczykutowicz M, et al (2020) Different Types of In vitro cultures of Schisandra chinensis and its cultivar (S. chinensis cv. Sadova): a rich potential source of specific lignans and phenolic compounds. In: Ramawat K, Ekiert H, Goyal S (eds) Plant cell and tissue differentiation and secondary metabolites. Reference series in phytochemistry. Springer, Cham, pp 1–28. https://doi.org/10.1007/978-3-030-11253-0_10-1
Thandavarayan R, Giridharan V, Arumugam S, Al E (2015) Schisandrin B prevents doxorubcin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling. PLoS ONE 10:119–214. https://doi.org/10.1371/journal.pone.0119214
Tong H, Zhao B, Du F, Al E (2012) Isolation and physicochemical characterization of polysaccharide fraction isolated from Schisandra chinensis. Chem Nat Compd 47:969–970. https://doi.org/10.1007/s10600-012-0116-5
Upton R, Graff A, Jolliffe G, et al (2011) Botanical pharmacognosy—microscopic characterization of botanical medicines. In: American herbal pharmacopoeia. p CRC Press
Urząd Rejestracji Produktów Leczniczych Wyrobów Medycznych i Produktów Biobójczych (2018) Schisandrae chinensis fructus. In: Farmakopea Polska XI. Rzeczpospolita Polska
Verpoorte R, Contin A, Memelink J (2002) Biotechnology for the production of plant secondary metabolites. Phytochem Rev 1:13–25. https://doi.org/10.1023/A:1015871916833
Waiwut P, Shin M, Yokoyama S, Al E (2012) Gomisin A enhances tumor necrosis factor-α-induced G1 cell cycle arrest via signal transducer and activator of transcription 1-mediated phosphotylation of retinoblastoma protein. Biol Pharm Bull 35:1997–2003. https://doi.org/10.1248/bpb.b12-00450
Wang Y, ** G (2009) Screening culture medium of Schisandra sphenanthera Rehd.et Wils’s induction and differentiation. Northern Horticulture
Wei X, Li H, Che P et al (2020) Comparing chloroplast genomes of traditional Chinese herbs Schisandra sphenanthera and S. chinensis. Chinese Herbal Medicines 12:247–256. https://doi.org/10.1016/j.chmed.2019.09.009
World Health Organization (2007) Monographs on selected medicinal plants, vol 3. Fructus Schisandrae, Geneva, pp 296–313
Wu L, **e B, Deng B, et al (2007) Callus induction in Schisandra sphenanthera Rehd. Et Wils. Nonwood Forest Research
**a Y, Yang B, Kuang X (2015) Schisandraceae triterpenoids: a review. Phytochem Rev 14:155–187. https://doi.org/10.1007/s11101-014-9343-7
**ao Y, Zhang H (2012) Homogeneous ionic liquid microextraction of the active constituents from fruits of Schisandra chinensis and Schisandra sphenanthera. Anal Chim Acta 712:78–84. https://doi.org/10.1016/j.aca.2011.11.033
**ao W, Yang L, Li L, Al E (2007) Sphenalactones A-D, a new class of high oxygenated trinotritrtpenoids from Schisandra sphenanthera. Tetrahedron Lett 48:5543–5546. https://doi.org/10.1016/j.tetlet.2007.05.152
**e J, Lee S, Chen X (2010a) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62:1064–1079.https://doi.org/10.1016/j.addr.2010.07.009
**e y, Hao H, Kang A, et al (2010b) Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers. J Ethnopharmacol 131:290–299.https://doi.org/10.1016/j.jep.2010.06.038
Xu L, Grandi N, Del Vecchio C, Al E (2015) From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. J Microbiol 53:288–293. https://doi.org/10.1007/s12275-015-4652-0
Xue YB, Zhang YL, Yang JH et al (2010) Nortriterpenoids and lignans from the fruit of Schisandra chinensis. Chem Pharm Bull 58:1606–1611. https://doi.org/10.1248/cpb.58.1606
Xue XP, Qin XL, Xu C et al (2013) Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats. Phytother Res 27:1255–1259. https://doi.org/10.1002/ptr.4849
Yan ZF, Guo J, Tian FH et al (2015) Active compounds from Schisandra chinensis exhibiting tyrosinase activity and melanin content inhibition in B16 melanoma cells. Biotechnol Bioprocess Eng 20:814–823. https://doi.org/10.1007/s12257-014-0867-x
Yim S, Lee Y, Lee Y, Al E (2009) Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptopic effects in hepatic carcinoma. Mol Med Rep 2:725–732. https://doi.org/10.3892/mmr_00000163
Zhang J, Chen J, Liang Z, Al E (2014) New lignans and their biological activites. Chem Biodivers 11:1–54. https://doi.org/10.1002/cbdv.201100433
Zhang SW, **n HuX, Shen C et al (2020) Protective effect of Schisandra chinensis extract against ethanol-induced gastric ulcers in mice by promoting anti-inflammatory and mucosal defense mechanisms. Rev Bras. https://doi.org/10.1007/s43450-020-00096-4
Zhao T, Mao G, Mao R, et al (2013a) Antitumor and immunomodulatory activity of a water-soluble low molecular weight poly saccharide from Schisandra chinensis (Turcz.) Baill. Food Chem Toxicol 55:609–616.https://doi.org/10.1016/j.fct.2013.01.041
Zhao X-N, Huang S, Zhao J, Zhang Y (2013b) Gender variation in a monoecious woody vine Schisandra chinensis (Schisandraceae) in northeast China. Annales Botanici Fennici 50:209–219. https://doi.org/10.5735/086.050.0402
Zhao T, Mao G, Feng W et al (2014) Isolation, characterization and antioxidant activity of polysaccharide from Schisandra sphenanthera. Carbohyd Polym 105:26–33. https://doi.org/10.1016/j.carbpol.2014.01.059
Zhou E, Li Y, Wei Z et al (2014) Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways. Int Immunopharmacol 22:133–140. https://doi.org/10.1016/j.intimp.2014.06.004
Zhu M, Chen XS, Wang KX (2007) Variation of the lignan content of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils. Chromatographia 66:125–128. https://doi.org/10.1365/s10337-007-0261-3
Zhu M, Yeung RY, Lin KF, Li RC (2000) Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model. Planta Med 66:521–525. https://doi.org/10.1055/s-2000-11202
Acknowledgments
Funding
This study was supported by the financial support of the funds of the Ministry of Science and Higher Education Programs: N42/DBS/000136 and N42/DBS/00121 and National Science Centre, Poland (grant number 2016/23/D/NZ7/01316).
Author Contribution Statement
All the authors read and approved the manuscript in its final form. All authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jafernik, K., Ekiert, H., Szopa, A. (2021). Schisandra chinensis and Schisandra sphenanthera—From Traditional Far Eastern Medicine to International Utilization. In: Ekiert, H.M., Ramawat, K.G., Arora, J. (eds) Medicinal Plants. Sustainable Development and Biodiversity, vol 28. Springer, Cham. https://doi.org/10.1007/978-3-030-74779-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-74779-4_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74778-7
Online ISBN: 978-3-030-74779-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)